MAPK8 and Alzheimer disease: The authors provided that miR-326 ameliorated AD progression and enhanced cell viability since miR-326 overexpression or/and JNK inhibition decreased Aβ1–40 and Aβ1–42 contents in brain tissues of AD mice.